Trial · NCT02799069
Registered outcomes35
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 20 of 35
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Percentage of Participants With Complete Response 12 Weeks After the Last Photodynamic Therapy (PDT), ITT | 12 weeks after the last PDT, up to 24 weeks after the first treatment | An overall complete responder was defined as a subject in whom all treated lesions were cleared (all lesions showing complete remission) 12 weeks after the last PDT. The outcome measure considered complete responders who were completely cleared 12 weeks after the first PDT and responders who were completely cleared 12 weeks after the second PDT if a re-treatment was necessary (in case of partial- or non-responding lesions 12 weeks after the first PDT) |
| Primary | Percentage of Participants With Complete Response 12 Weeks After the Last Photodynamic Therapy (PDT), PP | 12 weeks after the last PDT, up to 24 weeks after the first treatment | An overall complete responder was defined as a subject in whom all treated lesions were cleared (all lesions showing complete remission) 12 weeks after the last PDT. The outcome measure considered complete responders who were completely cleared 12 weeks after the first PDT and responders who were completely cleared 12 weeks after the second PDT if a re-treatment was necessary (in case of partial- or non-responding lesions 12 weeks after the first PDT) |
| Primary | Percentage of Participants With Complete Response 12 Weeks After the Last Photodynamic Therapy (PDT) Illuminated With Narrow Spectrum Devices Only | 12 weeks after the last PDT, up to 24 weeks after the first treatment | Subgroup analysis of patients treated with a narrow spectrum device for PDT Illumination (\~630 nm). An overall complete responder was defined as a subject in whom all treated lesions were cleared (all lesions showing complete remission) 12 weeks after the last PDT. The outcome measure considered complete responders who were completely cleared 12 weeks after the first PDT and responders who were completely cleared 12 weeks after the second PDT if a re-treatment was necessary (in case of partial- or non-responding lesions 12 weeks after the first PDT) |
| Secondary | Percentage of Participants With Complete Response 3-4 Weeks After First Photodynamic Therapy (PDT) | 3-4 weeks after the first PDT | A complete responder was defined as a subject in whom all treated lesions were cleared (all lesions showing complete remission) at 3-4 weeks after the first PDT. |
| Secondary | Percentage of Participants With Complete Response 12 Weeks After First Photodynamic Therapy (PDT) | 12 weeks after the first PDT | A complete responder was defined as a subject in whom all treated lesions were cleared (all lesions showing complete remission) at 12 weeks after the first PDT. |
| Secondary | Percentage of Participants With Complete Response 3-4 Weeks After the Second Photodynamic Therapy (PDT) | 3-4 weeks after the second PDT, 15-16 weeks after first treatment | A complete responder was defined as a subject in whom all treated lesions were cleared (all lesions showing complete remission) at 3-4 weeks after the second PDT. A second PDT was applied in case partial- or non-responding lesions remained 12 weeks after the first PDT. |
| Secondary | Percentage of Participants With Complete Response 12 Weeks After Second Photodynamic Therapy (PDT) | 12 weeks after the second PDT, 24 weeks after first treatment | A complete responder was defined as a subject in whom all treated lesions were cleared (all lesions showing complete remission) at 12 weeks after the second PDT. A second PDT was applied in case partial- or non-responding lesions remained 12 weeks after the first PDT. |
| Secondary | Percentage of Participants With Complete Response 3-4 Weeks After Last Photodynamic Therapy (PDT) | 3-4 weeks after the last PDT, up to 16 weeks after the first treatment | A complete responder at week 3-4 after treatment was defined as a subject in whom all treated lesions were cleared (all lesions showing complete remission). This outcome measure considered patients who were completely cleared at 3-4 weeks after the last PDT which included complete responders 3-4 weeks after the first and complete responders 3-4 weeks after the second PDT ( a second PDT was applied in case of remaining lesions 12 weeks after the first PDT). |
| Secondary | Percentage of Participants With Partial Response at 3-4 Weeks After First Photodynamic Therapy (PDT) | 3-4 weeks after the first PDT | A partial responder was defined as a subject in whom at least 75% of the treated lesions were cleared (lesions showing complete remission). This outcome measure considers partial responders at 3-4 weeks after the first PDT. |
| Secondary | Percentage of Participants With Partial Response at 12 Weeks After the First Photodynamic Therapy (PDT) | 12 weeks after the first PDT | A partial responder was defined as a subject in whom at least 75% of the treated lesions were cleared (lesions showing complete remission). This outcome measure considers partial responders at 12 weeks after the first PDT. |
| Secondary | Percentage of Participants With Partial Response at 3-4 Weeks After the Second Photodynamic Therapy (PDT) | 3-4 weeks after the second PDT, 15-16 weeks after first treatment | A partial responder was defined as a subject in whom at least 75% of the treated lesions were cleared (lesions showing complete remission). This outcome measure considers partial responders at 3-4 weeks after the second PDT. A second PDT was applied in case of partial- or non-responding lesions 12 weeks after the first PDT. |
| Secondary | Percentage of Participants With Partial Response at 12 Weeks After the Second Photodynamic Therapy (PDT) | 12 weeks after the second PDT, 24 weeks after first treatment | A partial responder was defined as a subject in whom at least 75% of the treated lesions were cleared (lesions showing complete remission). This outcome measure considers partial responders at 12 weeks after the second PDT. A second PDT was applied in case of partial- or non-responding lesions 12 weeks after the first PDT. |
| Secondary | Percentage of Participants With Partial Response at 3-4 Weeks After Last Photodynamic Therapy (PDT) | 3-4 weeks after the last PDT, up to 16 weeks after the first treatment | A partial responder was defined as a subject in whom at least 75% of the treated lesions were cleared (lesions showing complete remission). This outcome measure considers partial responders at 3-4 weeks after last PDT. The outcome measure combined partial responders with at least 75% of lesions cleared at 3-4 weeks after the first PDT or after the second PDT (a second PDT was applied in case of partial- or non-responding lesions 12 weeks after the first PDT). |
| Secondary | Percentage of Participants With Partial Response at 12 Weeks After Last Photodynamic Therapy (PDT) | 12 weeks after the last PDT, up to 24 weeks after first treatment | A partial responder was defined as a subject in whom at least 75% of the treated lesions were cleared (lesions showing complete remission). This outcome measure considers partial responders at 12 weeks after last PDT. The outcome measure combined partial responders with at least 75% of lesions cleared at 12 weeks after the first PDT and after the second PDT (a second PDT was applied in case of partial- or non-responding lesions 12 weeks after the first PDT) . |
| Secondary | Complete Lesion Response Rate 3-4 Weeks After First Photodynamic Therapy (PDT) | 3-4 weeks after the first PDT | Completely cleared individual lesions as defined at 3-4 weeks after first photodynamic therapy (PDT) |
| Secondary | Complete Lesion Response Rate 12 Weeks After First Photodynamic Therapy (PDT) | 12 weeks after the first PDT | Completely cleared individual lesions as defined at 12 weeks after the first photodynamic therapy (PDT). |
| Secondary | Complete Lesion Response Rate 3-4 Weeks After the Second Photodynamic Therapy (PDT) | 3-4 weeks after the second PDT, 15-16 weeks after first treatment | Completely cleared individual lesions as defined at 3-4 weeks after the second PDT. A second PDT was applied in case the individual lesion showed no or partial response12 weeks after first PDT. |
| Secondary | Complete Lesion Response Rate 12 Weeks After Second PDT | 12 weeks after the second PDT, 24 weeks after first treatment | Completely cleared individual lesions as defined at 12 weeks after second PDT. A second PDT was applied in case the individual lesion showed no or partial response 12 weeks after first PDT. |
| Secondary | Complete Lesion Response Rate 3-4 Weeks After Last Photodynamic Therapy (PDT) | 3-4 weeks after the last PDT, up to 16 weeks after first treatment | Completely cleared individual lesions defined at 3-4 weeks after the last PDT comprising of completely cleared individual lesions 3-4 weeks after the first and after the second PDT (a second PDT was applied in case lesions show no or partial response 12 weeks after the first PDT). |
| Secondary | Complete Lesion Response Rate 12 Weeks After Last Photodynamic Therapy (PDT) | 12 weeks after the last PDT, up to 24 weeks after first treatment | Completely cleared individual lesions 12 weeks after last PDT comprising of completely cleared individual lesions 12 weeks after the first or second PDT (a second PDT was applied in case individual lesions show no or partial response 12 weeks after first PDT). |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02799069/registered